
Sign up to save your podcasts
Or


This podcast is a discussion of a clinical trial by Lesokhin et al which evaluated nivolumab monotherapy in patients with relapsed or refractory hematologic malignancies.
By American Society of Clinical Oncology (ASCO)3.8
3939 ratings
This podcast is a discussion of a clinical trial by Lesokhin et al which evaluated nivolumab monotherapy in patients with relapsed or refractory hematologic malignancies.

14,364 Listeners

137 Listeners

320 Listeners

498 Listeners

58 Listeners

112,758 Listeners

44 Listeners

32 Listeners

195 Listeners

90 Listeners

364 Listeners

253 Listeners

189 Listeners

41 Listeners

613 Listeners